| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Tissue Studies Section, Laboratory of Experimental Pathology, National Cancer Institute, Bethesda, Maryland 20014 [H. A., C. C. H.]; Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [J. M. E., R. G. C., G. N. W.]; and Department of Pathology, University of Maryland Medical School, Baltimore, Maryland 21201 [B. F. T.]
Aflatoxin B1 and benzo(a)pyrene were activated by both cultured human bronchus and human colon as measured by binding to cellular DNA and protein. The binding of aflatoxin B1 to DNA was dose dependent, and the level of binding was higher in cultured human bronchus than it was in the colon. When compared to aflatoxin B1, the binding level of benzo(a)pyrene to both bronchial and colonic DNA was generally higher. The major adducts formed in both tissues by the interaction of aflatoxin B1 and DNA were chromatographically identical to 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 (Structure I) with the guanyl group and hydroxy group in trans-position and an adduct which has been tentatively identified by other investigators as 2,3-dihydro-2-(N5-formyl-2',5',6'-triamino-4'-oxo-N5-pyrimidyl)-3-hydroxyaflatoxin B1 (Structure II). Seventy % of the radio-activity associated with bronchial DNA was found in these two peaks, and the ratio of radioactivity between the peaks was nearly 1. In colonic DNA, the ratio between Structures I and II was approximately 2. These observations add aflatoxin B1 to the list of chemical procarcinogens metabolized by cultured human tissues and in which the carcinogen-DNA adducts are similar to the adducts formed in animal tissue susceptible to the carcinogenic action of aflatoxin B1.
1 This work was supported in part by Contracts N01-CP 43265 and N01-CP-43237 from the NIH.
2 To whom request for reprints should be addressed.
Received 7/14/78. Accepted 11/14/78.
This article has been cited by other articles:
![]() |
T. R. Van Vleet, T. L. Watterson, P. J. Klein, and R. A. Coulombe Jr. Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells Toxicol. Sci., February 1, 2006; 89(2): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |